Stocks and Investing Stocks and Investing
Wed, August 16, 2023

Anupam Rama Maintained (SNDX) at Buy with Decreased Target to $33 on, Aug 16th, 2023


Published on 2024-10-28 05:56:36 - WOPRAI, Anupam Rama
  Print publication without navigation


Anupam Rama of JP Morgan, Maintained "Syndax Pharmaceuticals, Inc." (SNDX) at Buy with Decreased Target from $36 to $33 on, Aug 16th, 2023.

Anupam has made no other calls on SNDX in the last 4 months.



There are 7 other peers that have a rating on SNDX. Out of the 7 peers that are also analyzing SNDX, 0 agree with Anupam's Rating of Hold.



These are the ratings of the 7 analyists that currently disagree with Anupam


  • Edward White of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $38 on, Friday, August 4th, 2023
  • George Farmer of "Scotiabank" Initiated at Buy and Held Target at $39 on, Thursday, July 27th, 2023
  • Peter Lawson of "Barclays" Maintained at Buy with Increased Target to $34 on, Wednesday, July 26th, 2023
  • Yigal Nochomovitz of "Citigroup" Maintained at Strong Buy with Increased Target to $35 on, Wednesday, July 26th, 2023
  • Kalpit Patel of "B. Riley Securities" Maintained at Strong Buy with Increased Target to $36 on, Tuesday, July 25th, 2023
  • Michael Schmidt of "Guggenheim" Maintained at Strong Buy with Increased Target to $42 on, Tuesday, July 25th, 2023
  • Justin Zelin of "BTIG" Maintained at Strong Buy with Increased Target to $35 on, Monday, June 26th, 2023
Contributing Sources